Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benibest: Olmesartan treatment algorithm for hypertension
NCT00890591Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Aug 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of olmesartan in essential hypertension, sponsored by Daiichi Sankyo Co., Ltd.. Started Aug 2006; status: completed.
02
Drugs
olmesartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00890591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00890591.